Knowledge of the Pharmacology of Antidepressants and Antipsychotics Yields Results Comparable With Pharmacogenetic Testing-Reference-Cited by-同舟云学术

Knowledge of the Pharmacology of Antidepressants and Antipsychotics Yields Results Comparable With Pharmacogenetic Testing

Published:2018-11 Issue:6 Volume:24 Page:416-419
ISSN:1538-1145
Container-title:Journal of Psychiatric Practice
language:en
Short-container-title:

Author:

MACALUSO MATTHEW,PRESKORN SHELDON H.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference6 articles.

1. Does pharmacogenomic testing improve clinical outcomes for major depressive disorder? A systematic review of clinical trials and cost-effectiveness studies;Rosenblat;J Clin Psychiatry,2017

2. Utility of integrated pharmacogenomic testing to support the treatment of major depressive disorder in a psychiatric outpatient setting;Hall-Flavin;Pharmacogenet Genomics,2013

3. Using a pharmacogenomic algorithm to guide the treatment of depression;Hall-Flavin;Transl Psychiatry,2012

4. A prospective, randomized, double-blind study assessing the clinical impact of integrated pharmacogenomic testing for major depressive disorder;Winner;Discov Med,2013

5. Results of the STAR*D study: implications for clinicians and drug developers;Preskorn;J Psychiatr Pract,2009

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenomic Clinical Support Tools for the Treatment of Depression;American Journal of Psychiatry;2024-07-01

2. Recent advances in dopamine D ₂ receptor ligands in the treatment of neuropsychiatric disorders;Medicinal Research Reviews;2022-09-16

3. Pharmacogenomics and antidepressants: efficacy and adverse drug reactions;Psychiatric Genomics;2022

4. Association of sleep among 30 antidepressants: a population-wide adverse drug reaction study, 2004–2019;PeerJ;2020-03-11

5. Good, better, best: clinical scenarios for the use of L-methylfolate in patients with MDD;CNS Spectrums;2019-12-13